Navigation Links
RayBiotech, Inc. and Abeome Corporation Announce an Agreement Related to Novel Research Products for Ovarian Cancer
Date:11/1/2012

NORCROSS, Ga., Nov. 1, 2012 /PRNewswire/ -- RayBiotech, Inc. and Abeome Corporation today announced that the companies have entered into a collaboration whereby Abeome will provide over 300 novel monoclonal antibodies recognizing human ovarian cancer for use in the development of RayBiotech's antibody-related portfolio of products.  These antibodies recognize ovarian cancer but not normal ovary tissue.  Financial terms were not disclosed.

RayBiotech's President, Chief Operating Officer and Co-Founder, Rani Huang stated, "Ovarian cancer is a devastating disease and most often goes undetected until very late stages of progression.  This alliance with Abeome will enable RayBiotech to provide products and services for the preclinical characterization of ovarian cancer-related biological samples.  We are delighted to have entered into this agreement with another Georgia-based bioreagent company."

Abeome's President and CEO, Dr. Richard Shimkets said, "We are very pleased to be working with RayBiotech in providing key reagents for studying ovarian cancer.   These antibodies, made with Abeome's patented DiSH™ technology, are the result of a unique direct immunization of mice with human ovarian cancer cells.   It is our hope that their use will help define better diagnostic and therapeutic options for ovarian cancer patients."

About RayBiotech, Inc.

In 2001 RayBiotech (http://www.raybiotech.com) introduced the first commercially available cytokine antibody array. With a focus on translating scientific knowledge into improved health, RayBiotech continues to pioneer advances in high-throughput platforms for identifying disease mechanisms, screening and validation of biomarkers and identification of drug targets.  RayBiotech products are featured in hundreds of publications, including: Nature, Nature Medicine, Cell, Lancet, PNAS and many others. Offering the largest selection of protein arrays, RayBiotech has established a reputation for high quality and innovation in the research community. A spin-off from Emory University, RayBiotech is privately owned, with headquarters in metropolitan Atlanta.

About Abeome Corporation

Abeome (www.abeomecorp.com) has developed and patented novel technology for the rapid discovery of high quality monoclonal antibodies, and manufactures kits and specialized growth media to allow researchers to use that technology in their own laboratories.  To date Abeome has made over 2000 monoclonal antibodies, alone or in collaboration with numerous pharmaceutical and biotechnology companies, using its proprietary technologies.   Abeome is based in Athens, Georgia.

About Ovarian Cancer

Approximately 22,000 women in the United States will develop ovarian cancer in 2012, 80% of which will not live more than 5 years after diagnosis.  Ovarian cancer is very treatable if detected early, but limited screening options are available that can detect early-stage disease.  In September of 2012, an expert panel of the United Stated Preventative Services Task Force concluded that existing diagnostic tests do more harm than good in screening healthy woman, as high false-positive results (~10%) lead to more than 1000 unnecessary surgeries per year, 15% of which have serious complications.

For More Information:

Rob Burgess, PhD
Director, Business Development
RayBiotech, Inc.
Phone: 770-729-2992
Email: rob@raybiotech.com

Richard Shimkets, PhD
President and CEO, Abeome Corporation
Phone: 706-542-7889
Email: rick.shimkets@abeomecorp.com

 


'/>"/>
SOURCE RayBiotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CombiMatrix Corporation Selects Cartagenia BENCHlab CNV Platform to Bolster Expanded Lab Operations
2. United Therapeutics Corporation Reports Third Quarter 2012 Financial Results
3. Fish & Richardson Prevails in Patent Infringement Trial for Volcano Corporation
4. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
5. Luminex Corporation Reports Third Quarter 2012 Results
6. Unilife Corporation Reschedules Release Of Quarterly Results And Earnings Call Due To Severe Weather In Northeastern U.S.
7. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
8. Unilife Corporation To Announce Financial Results For Fiscal 2013 First Quarter On Tuesday, October 30, 2012
9. Harvest Technologies Corporation reicht Patentverletzungsklage gegen ThermoGenesis Corporation ein
10. Harvest Technologies Corporation Files Patent Infringement Complaint against ThermoGenesis Corporation
11. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2, 2016 Research and Markets has announced ... Growth and Demand Forecast to 2022" report to their offering. ... , , ... in 2015, and it is expected to grow at a CAGR of ... to witness faster growth during the forecast period, a CAGR of 8.8% ...
(Date:12/2/2016)... Dec. 2, 2016 In the first ever ... from those derived from C. sativa, the Hebrew University ... di Napoli Federico II , the Universita` del Piemonte ... comprehensive, critical, integrated and unified inventory of phytocannabinoids of ... focuses on the remarkable chemical and structural diversity of ...
(Date:12/2/2016)... , Dec. 2, 2016  Maxor National Pharmacy Services, ... of Pharmaceutical Specialties, Inc. ("PSI").  The combination of ... Georgia -based PSI bring together both company,s clinical ... manufacturers, and payers an industry-leading specialty pharmacy. About ... , , ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... ... Halfway through its partnership with First 5 LA, Western University of Health ... children 5 years old and younger and treatment services to more than 9,100 of ... years to Western University of Health Sciences, UCLA and USC, beginning March 1, 2013, ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... 02, 2016 , ... Center for Autism and Related Disorders (CARD) Portland today ... spectrum disorder (ASD) and other developmental disabilities. The group, which is being launched with ... caregivers the opportunity to share stories and advice, seek help, and continue their education ...
(Date:12/2/2016)... ... 02, 2016 , ... Mediaplanet’s newest campaign, “Digestive Heath,” hits ... proof that attitude and determination can combine into the most remarkable achievements. Over ... holidays. This campaign will offer patients a new-found hope, by seizing the opportunity ...
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, a class-leading provider of ... Lite. CloudLIMS Lite helps biobanks, clinical, research and testing laboratories keep track of ... new version is a faster and a more efficient product, allowing batch processing ...
Breaking Medicine News(10 mins):